Senate Hears NIH Funding Woes

Top brass at the US science agency aired monetary grievances before a Senate committee last week.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, U.S. DEPARTMENT OF THE TREASURYThe already slim budget for the National Institutes of Health (NIH) is being further sapped by the government-wide sequester to the point that a whole generation of US scientists is at risk, according to agency director Francis Collins. After highlighting “exciting new initiatives” at the NIH and praising President Barack Obama’s $31.3 billion 2014 budget request for the agency, Collins bemoaned the belt tightening that the sequestration—a 10-year, across the board cut to discretionary funding mandated by the Budget Control Act—has set in motion.

“If the Budget Control Act-imposed caps on discretionary programs continue, and NIH funding is reduced proportionally over the next 10 years, funding will decline by about $19 billion,” Collins told the US Senate’s Subcommittee on Labor, Health and Human Services, Education last Wednesday (May 15). “The consequences will be harmful to scientific progress and to American leadership in science.”

The sequestration would cut 5 percent of the NIH’s appropriation, essentially eliminating the 1.5 percent provided by Obama’s 2014 budget and leaving the agency $1.6 billion short of its 2013 budget. And if the sequester remains in place for a decade, NIH funding would suffer the $19 billion loss Collins mentioned in his plea to the Subcommittee.

“At a time when global competition in the life ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies